FrancophonIA/ELRC3.0 huggingface dataset:
English: Laboratorios Hipra, S.A. Carretera C-63 Km 48.300 Polígon Industrial El Rieral, 17170 Amer (Girona) Spain
Danish: Laboratorios Hipra, S.A. Carretera C-63 Km 48.300 Polígon Industrial El Rieral, 17170 Amer (Girona) Spanien
English: Use only sterile needles and syringes for administration.
Danish: Brug kun sterile kanyler og sprøjter til indgivelse.
English: Primary vaccination (nasal use): Spray 1 ml into each nostril (so the total volume administered is 2 ml).
Danish: Primær vaccination (nasal brug): Sprøjt 1 ml i hvert næsebor (så den samlede indgivne mængde er 2 ml).
English: Nasal use or intramuscular use.
Danish: Nasal eller intramuskulær anvendelse.
English: Phosphate buffer solution
Danish: Phosphatbufferopløsning
English: Do not mix with any other veterinary medicinal product, except with the solvent supplied for use with the veterinary medicinal product .
Danish: Må ikke blandes med andre lægemidler til dyr undtaget solvens, der leveres til brug med dette veterinærlægemiddel.
English: 5 doses 25 doses
Danish: 5 doser 25 doser
English: To stimulate active immunity against bovine respiratory syncytial virus.
Danish: Til stimulering af aktiv immunitet mod bovint respiratorisk syncytialvirus.
English: Primary vaccination (intramuscular injection): One intramuscular injection of 2 ml should be given, followed by a second intramuscular injection of 2 ml given 4 weeks later.
Danish: Primær vaccination (intramuskulær injektion): Der skal gives én intramuskulær injektion på 2 ml, efterfulgt af en yderligere intramuskulær injektion på 2 ml, givet 4 uger efter.
English: Active immunisation of cattle to reduce virus shedding and respiratory clinical signs caused by bovine respiratory syncytial virus infection.
Danish: Aktiv immunisering af kvæg for at reducere virusspredning og kliniske luftvejssymptomer på grund af infektion med bovint respiratorisk syncytial virus.
English: Lyophilisate: Store and transport refrigerated (2 °C - 8 °C).
Danish: Lyofilisat: Opbevares og transporteres nedkølet (2°C - 8°C).
English: Slight alteration of faecal consistency may be commonly observed post-vaccination.
Danish: Det er almindeligt at opleve lettere ændringer i afføringens konsistens efter vaccinationen.
English: EXP {month/year} Once reconstituted use immediately.
Danish: EXP {måneder/år} Anvendes straks efter rekonstitution.
English: Inject the 10 ml of solvent into the vial containing the lyophilisate (freeze-dried powder).
Danish: Injicer derefter 10 ml solvens ind i hætteglasset med lyofilisatet (det frysetørrede pulver).
English: Live attenuated bovine respiratory syncytial virus, strain Lym-56.
Danish: Levende svækket, bovint respiratorisk syncytial virus, stamme Lym-56.
English: Revaccination: One intramuscular injection of 2 ml should be given 6 months after completion of the primary vaccination scheme and then every 6 months after the last revaccination.
Danish: Revaccination: En intramuskulær injektion på 2 ml skal gives 6 måneder efter afslutningen af det primære vaccinationsforløb og derefter hver 6. måned efter den sidste revaccination.
English: Revaccination: One intramuscular injection of 2 ml should be given 2 months after the primary vaccination, and then every 6 months after the last revaccination.
Danish: Revaccination: Der skal give én intramuskulær injektion på 2 ml 2 måneder efter den primære vaccination, og derefter hver 6. måned efter den seneste revaccination.
English: 5 doses
Danish: 5 doser
English: 10 vials of lyophilisate (50 doses) 10 vials of lyophilisate (250 doses)
Danish: 10 hætteglas med lyofilisat (50 doser) 10 hætteglas med lyofilisat (250 doser)
English: Solvent: Polyethylene (PET) vials of 10 ml or 50 ml, sealed with a bromobutyl rubber stopper and aluminium cap.
Danish: Solvens: Hætteglas i polyethylen (PET) på 10 eller 50 ml, lukket med en brombutylgummiprop og aluminiumshætte.
English: Lyophilisate (vaccine): 10 ml type I glass vials of 5 or 25 doses, sealed with a bromobutyl rubber stopper and aluminium cap.
Danish: Lyofilisat (vaccine): Hætteglas af glastype I på 10 ml med 5 eller 25 doser, lukket med en brombutylgummiprop og aluminiumshætte.
English: Phosphate buffer solution Lyophilisate: Whitish freeze-dried lyophilisate.
Danish: Phosphatbufferopløsning Lyofilisat: Hvidligt, frysetørret lyofilisat.
English: 10 vials of solvent (100 ml) 10 vials of solvent (500 ml)
Danish: 10 hætteglas med solvens (100 ml) 10 hætteglas med solvens (500 ml)
English: Potassium dihydrogen phosphate Dipotassium phosphate
Danish: Kaliumdihydrogenphospat Dikaliumphosphat
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Cardboard box (1x5 doses and 1x25 doses)
Danish: OPLYSNINGER, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE Kartonæske (1x5 doser og 1x25 doser)
English: Peel the top off the aluminium cap on the vial containing the solvent, and withdraw 10 ml.
Danish: Træk det øverste af aluminiumslåget af hætteglasset med solvensen, og træk 10 ml op. 2.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Cardboard box for solvent (10 x 10 ml and 10 x 50 ml)
Danish: OPLYSNINGER, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE Kartonæske til solvens (10x10 ml og 10x50 ml)
English: 1 vial of lyophilisate and 1 vial of solvent (5 doses) 1 vial of lyophilisate and 1 vial of solvent (25 doses)
Danish: 1 hætteglas med lyofilisat og 1 hætteglas med solvens (5 doser) 1 hætteglas med lyofilisat og 1 hætteglas med solvens (25 doser)
English: Potassium chloride Water for injections
Danish: Vand til injektionsvæsker
English: A. MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Danish: A. <FREMSTILLER<(E)> AF DE(T) BIOLOGISK AKTIVE STOF< (FER) > OG> FREMSTILLER<(E) > ANSVARLIG FOR BATCHFRIGIVELSE
English: la Selva 135, 17170 Amer (Girona) Spain
Danish: la Selva 135, 17170 Amer (Girona) Spanien
English: Number of doses in vial of lyophilisate
Danish: Antal doser i hætteglas med lyofilisat
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Cardboard box for lyophilisate (10 x 5 doses and 10 x 25 doses)
Danish: OPLYSNINGER, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE Kartonæske til lyofilisat (10x5 doser og 10x25 doser)
English: Lyophilisate: Whitish freeze-dried lyophilisate.
Danish: Lyofilisat: Hvidligt, frysetørret lyofilisat.
English: Cardboard box with 1 lyophilisate vial of 25 doses and 1 vial of 50 ml of solvent.
Danish: Kartonæske med 1 hætteglas med lyofilisat à 25 doser og 1 hætteglas à 50 ml solvens.
English: Cardboard box with 10 vials of 10 ml of solvent.
Danish: Kartonæske med 10 hætteglas à 10 ml solvens.
English: Each dose of 2 ml contains: Live attenuated bovine respiratory syncytial virus, strain Lym-56 ................... 104.7 - 6.5 CCID50
Danish: Hver dosis på 2 ml indeholder: Levende svækket bovint, respiratorisk syncytial virus, stamme Lym-56 ........ 104,7 - 6,5 CCID50
English: Cardboard box with 10 lyophilisate vials of 25 doses.
Danish: Kartonæske med 10 hætteglas med lyofilisat à 25 doser.
English: Live attenuated bovine respiratory syncytial virus (BRSV), strain Lym-56 ..... 104.7 - 6.5 CCID50* *Cell culture infectious dose 50%
Danish: Levende, svækket bovint respiratorisk syncytial virus (BRSV), stamme Lym-56 104,7 - 6,5 CCID50* *Infektionsdosis i cellekultur 50 %
English: Cardboard box with 1 lyophilisate vial of 5 doses and 1 vial of 10 ml of solvent.
Danish: Kartonæske med 1 hætteglas med lyofilisat à 5 doser og 1 hætteglas à 10 ml solvens.
English: Each dose of 2 ml contains: Live attenuated bovine respiratory syncytial virus, strain Lym-56 ................... 104.7 - 6.5 CCID50*
Danish: Hver dosis på 2 ml indeholder: Levende svækket, bovint respiratorisk syncytial virus, stamme Lym-56 ........ 104,7 - 6,5 CCID50*
English: Live attenuated bovine respiratory syncytial virus, strain Lym-56 ................... 104.7 - 6.5 CCID50* *Cell culture infectious dose 50%
Danish: Levende svækket, bovint respiratorisk syncytial virus, stamme Lym-56 ........ 104,7 - 6,5 CCID50* *Infektionsdosis i cellekultur 50 %
English: Cardboard box with 10 vials of 50 ml of solvent.
Danish: Kartonæske med 10 hætteglas à 50 ml solvens.
English: Cardboard box with 10 lyophilisate vials of 5 doses.
Danish: Kartonæske med 10 hætteglas med lyofilisat à 5 doser.
English: NASYM lyophilisate for suspension for injection or nasal spray for cattle
Danish: NASYM lyofilisat til injektionsvæske, suspension eller næsespray til kvæg
English: Lyophilisate:
Danish: INDLÆGSSEDDEL:
English: NASYM lyophilisate and solvent for suspension for injection or nasal spray for cattle.
Danish: NASYM lyofilisat og solvens til injektionsvæske, suspension eller næsespray til kvæg.
English: No adverse reactions other than those described in section 4.6 occurred following the administration of an overdose.
Danish: Efter indgivelse af en overdosis, blev der ikke observeret andre bivirkninger end de, der er anført i pkt.
English: NASYM lyophilisate and solvent for suspension for injection or nasal spray for cattle NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT
Danish: NAVN OG ADRESSE PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN SAMT PÅ DEN INDEHAVER AF VIRKSOMHEDSGODKENDELSE, SOM ER ANSVARLIG FOR BATCHFRIGIVELSE, HVIS FORSKELLIG HERFRA
English: Lyophilisate and solvent for suspension for injection or nasal spray.
Danish: Lyofilisat og solvens til injektionsvæske, suspension eller næsespray.
English: NASYM lyophilisate and solvent for suspension for injection or nasal spray for cattle
Danish: NASYM lyofilisat og solvens til injektionsvæske, suspension eller næsespray til kvæg
English: Lyophilisate and solvent for suspension for injection or nasal spray
Danish: Lyofilisat og solvens til injektionsvæske, suspension eller næsespray
English: Lyophilisate for suspension for injection or nasal spray
Danish: Lyofilisat til injektionsvæske, suspension eller næsespray
English: Solvent for suspension for injection or nasal spray
Danish: Solvens til injektionsvæske, suspension eller næsespray
English: Marketing authorisation holder and manufacturer responsible for batch release: Laboratorios Hipra, S.A.
Danish: Indehaver af markedsføringstilladelsen og fremstiller ansvarlig for batchfrigivelse:
English: Potassium dihydrogen phosphate Disodium phosphate dodecahydrate Sodium chloride
Danish: Dinatriumphosphatdodecahydrat Natriumchlorid
English: Avda.
Danish: A.
English: 21 days after administration of one dose by the nasal route.
Danish: Indtræden af immunitet: 21 dage efter administration af dosis gennem næsen.
English: Special precautions to be taken by the person administering the veterinary medicinal product to animals:
Danish: Særlige forholdsregler der skal træffes af personer, der administrerer lægemidlet til dyr: I tilfælde af selvinjektion ved hændeligt uheld skal der straks søges lægehjælp, og indlægssedlen eller etiketten bør vises til lægen.
English: EU/2/06/065/001 ProMeris Duo 100.5 mg metaflumizone and 100.5 mg amitraz
Danish: EU/2/06/065/001 ProMeris Duo 100,5 mg metaflumi-zon og 100,5 mg amitraz
English: Packaging Content Package size Withdrawal Period
Danish: Emballage Indhold Pakningsstørrelse
English: Pharmaceut ical Form
Danish: Lægemiddel form
English: Invented Name
Danish: Produktnavn Styrke
English: EU/1/19/1388/001 Polivy
Danish: EU/1/19/1388/001
English: Powder for concentrate for solution for infusion
Danish: 140 mg Pulver til koncentrat til infusionsvæske, opløsning.
English: Pack size
Danish: Polivy
English: 1 vial
Danish: Hætteglas 1 hætteglas
English: EMA/808930/2011 corr. EMEA/H/C/001225
Danish: EMA/990712/2011 EMEA/H/C/001225
English: Treatment may continue for as long as the doctor considers that the patient is benefiting from it.
Danish: Behandlingen kan fortsætte, så længe lægen anser det for at være til fordel for patienten.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Colobreathe on 13 February 2012.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Colobreathe den 13. februar 2012.
English: The recommended dose is one capsule twice daily, taken as close as possible to 12 hours apart.
Danish: Den anbefalede dosis er én kapsel to gange dagligt, så vidt muligt med 12 timers mellemrum.
English: FEV1 is the most air a person can breathe out in one second.
Danish: FEV1 er den størst mulige mængde luft, som en person kan udånde på ét sekund.
English: The full EPAR for Colobreathe can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Danish: Den fuldstændige EPAR for Colobreathe findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: This is a summary of the European public assessment report (EPAR) for Colobreathe.
Danish: Dette er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Colobreathe.
English: The packs will contain information on the need to comply with treatment, instructions on how to use the medicine and information on side effects.
Danish: Pakkerne vil indeholde information om nødvendigheden af at overholde behandlingen, anvisninger for brug af medicinen og information om bivirkninger.
English: The very first dose at the start of the treatment should be taken under medical supervision.
Danish: Ved begyndelsen af behandlingen skal den allerførste dosis tages under lægeligt opsyn.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Colobreathe.
Danish: Det forklarer, hvordan Udvalget for Lægemidler til Mennesker (CHMP) vurderede lægemidlet og nåede frem til sin udtalelse til fordel for udstedelse af en markedsføringstilladelse og til sine anbefalinger om anvendelsesbetingelserne for Colobreathe.
English: In addition, the Committee noted that patients generally prefer inhaling powder to using a nebuliser.
Danish: Desuden bemærkede udvalget, at de fleste patienter foretrækker at inhalere et pulver frem for at bruge en nebulisator.
English: The Committee therefore decided that the benefits of Colobreathe are greater than its risks and recommended that it be given marketing authorisation.
Danish: Udvalget afgjorde derfor, at fordelene ved Colobreathe overstiger risiciene, og anbefalede udstedelse af markedsføringstilladelse.
English: The company that makes Colobreathe will supply education packs to patients and healthcare professionals.
Danish: Den virksomhed, der fremstiller Colobreathe, vil udlevere uddannelsespakker til patienter og medicinsk personale.
English: The effects of Colobreathe were first tested in experimental models before being studied in humans.
Danish: Virkningerne af Colobreathe blev først afprøvet i forsøgsmodeller, inden de blev undersøgt hos mennesker.
English: For more information about treatment with Colobreathe, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med Colobreathe, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: They are not to be inhaled using any other device.
Danish: Indholdet af kapslerne må ikke inhaleres med nogen anden anordning.
English: If the patient is also receiving other treatments for cystic fibrosis, they should be taken in the following order: inhaled bronchodilator, chest physiotherapy, other inhaled medicines and then Colobreathe.
Danish: Hvis patienten også får anden behandling for cystisk fibrose, skal behandlingerne tages i følgende rækkefølge: Inhaleret bronkodilator, thoraxfysioterapi, anden inhalationsmedicin og derefter Colobreathe.
English: The most common side effects seen with Colobreathe in studies were: unpleasant taste, cough, throat irritation, difficulty breathing and dysphonia (difficulty speaking).
Danish: De mest almindelige bivirkninger af Colobreathe i undersøgelserne var: ubehagelige smagsindtryk, irritation i halsen, åndedrætsbesvær og dysfoni (talevanskeligheder).
English: Among patients that completed the study, the improvement in FEV1 adjusted for age and height was 0.39% with Colobreathe compared with 0.78% with tobramycin.
Danish: De patienter, der gennemførte undersøgelser, fik forbedret deres FEV1, korrigeret for alder og højde, med 0,39 % med Colobreathe, sammenholdt med 0,78 % for tobramycin.
English: The main measure of effectiveness was based on the improvement in FEV1, adjusted for the patients' age and height, after 24 weeks.
Danish: Behandlingens virkning blev hovedsagelig bedømt på bedringen i patienternes FEV1, korrigeret for alder og højde, efter 24 uger.
English: Colobreathe is a medicine that contains the active substance colistimethate sodium.
Danish: Colobreathe er et lægemiddel, der indeholder det aktive stof colistimethatnatrium.
English: What measures are being taken to ensure the safe use of Colobreathe?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri anvendelse af Colobreathe?
English: Colobreathe must not be used in people who are hypersensitive (allergic) to colistimethate sodium or to colistin sulphate or polymyxin B.
Danish: Colobreathe bør ikke anvendes hos patienter, der er overfølsomme (allergiske) over for colistimethatnatrium, colistinsulfat eller polymyxin B.
English: The active substance in Colobreathe, colistimethate sodium, is an antibiotic from the polymyxin group.
Danish: Det aktive stof i Colobreathe, colistimethatnatrium, er et antibiotikum i polymyxingruppen.
English: The side effects seen with Colobreathe were considered acceptable.
Danish: Bivirkningerne af Colobreathe blev anset for acceptable.
English: The accumulation of mucus in the lungs allows bacteria to grow more easily causing infections, lung damage and breathing problems.
Danish: Ophobningen af slim i lungerne gør det nemmere for bakterierne at formere sig, så der kommer infektioner, lungebeskadigelse og åndedrætsbesvær.
English: The patients' condition had been stabilised by treatment with tobramycin before the study.
Danish: Patienternes sygdom var inden undersøgelsen blevet stabiliseret ved behandling med tobramycin.
English: Other information about Colobreathe
Danish: Andre oplysninger om Colobreathe:
English: Colobreathe, as a powder for inhalation, is expected to be more convenient for patients than nebulisers.
Danish: Da Colobreathe er et inhalationspulver, forventes det at være behageligere for patienterne end en nebulisator.
English: It is available as capsules containing a powder for inhalation using an inhaler device.
Danish: Det leveres som kapsler, der indeholder et inhalationspulver, der inhaleres (indåndes) ved hjælp af en inhalator.
English: Cystic fibrosis is an inherited disease that affects the cells in the lungs and the glands in the gut and pancreas which secrete fluids such as mucus and digestive juices.
Danish: Cystisk fibrose er en arvelig sygdom, der angriber cellerne i lungerne og de kirtelceller i tarmen og bugspytkirtlen, der udskiller slim og fordøjelsesvæsker.
English: Bacterial lung infection with P. aeruginosa is frequent in cystic fibrosis patients.
Danish: Infektioner forårsaget af bakterien P. aeruginosa er almindelige ved cystisk fibrose.
English: The contents of Colobreathe capsules are inhaled using a powder inhaler called Turbospin.
Danish: Indholdet af kapslerne med Colobreathe indåndes hjælp en "Turbospin" pulverinhalator.
English: No more serious side effects were seen with Colobreathe than with tobramycin.
Danish: Colobreathe medførte ikke alvorligere bivirkninger end tobramycin.
English: For the full list of all side effects reported with Colobreathe, see the package leaflet.
Danish: Den fuldstændige liste over indberettede bivirkninger ved Colobreathe fremgår af indlægssedlen.
English: Colobreathe is used to manage long-term lung infection caused by the bacteria Pseudomonas aeruginosa in patients aged six years and over who have cystic fibrosis.
Danish: Colobreathe anvendes til behandling af langvarig lungebetændelse forårsaget af bakterien Pseudomonas aeruginosa hos patienter over 60 år med cystisk fibrose.
English: The CHMP concluded that the modest improvement in FEV1 seen with Colobreathe was sufficient evidence of the medicine's effectiveness, given that larger improvements would not be expected in patients whose condition was already stabilised on tobramycin nebuliser.
Danish: CHMP konkluderede, at den beskedne forbedring i FEV1, der fås med Colobreathe, var tilstrækkeligt bevis for lægemidlets effektivitet, når det tages i betragtning, at større bedring ikke kan forventes, når patientens tilstand i forvejen er stabiliseret med en tobramycin nebulisator.
English: Polymyxins work by disrupting the cell membrane of bacteria by interacting with certain components of the membrane called phospholipids.
Danish: Polymyxiner virker ved at sprænge bakteriernes cellevæg, idet det angriber de bestanddele i cellevæggen, der hedder fosfolipider.
English: Why has Colobreathe been approved?
Danish: Hvorfor blev Colobreathe godkendt?
English: The improvements in FEV1 seen with Colobreathe were considered sufficient proof of effectiveness, considering the fact that the patients in the study were already stabilised on tobramycin nebuliser.
Danish: Forbedringerne i FEV1 med Colobreathe blev anset for tilstrækkeligt bevis for virkningen, da patienterne i undersøgelsen i forvejen var stabiliseret med en tobramycin nebulisator.
English: Colobreathe compared well with the tobramycin treatment, considering the fact that the patients were already stabilised on tobramycin nebuliser.
Danish: Colobreathe stod godt mål med tobramycin i betragtning af, at patienterne i forvejen var stabiliseret med tobramycin nebulisator.
English: What is the risk associated with Colobreathe?
Danish: Hvilken risiko er der forbundet med Colobreathe?
English: What is Colobreathe?
Danish: Hvad er Colobreathe?
English: EPAR summary for the public colistimethate sodium
Danish: EPAR - sammendrag for offentligheden
English: Colobreathe was compared with another medicine, tobramycin nebuliser solution, in 380 cystic fibrosis patients aged six years and above with P. aeruginosa lung infection.
Danish: Colobreathe blev sammenlignet med en anden medicin, tobramycin inhalationsvæske til nebulisator, hos 380 patienter med cystisk fibrose.
English: How has Colobreathe been studied?
Danish: Hvordan blev Colobreathe undersøgt?
English: Inhalation may also lead to coughing or bronchospasm (tightening of the muscles in the airway), which may be controlled by first treating the patients with inhaled beta-2 agonist medicines.
Danish: Dette kan begrænses ved forudgående behandling med inhalation af en type medicin, der kaldes beta-2-agonister.
English: Polymyxins target a group of bacteria called Gram-negative bacteria, which includes P. aeruginosa, because their cell membranes contain a high level of phospholipids.
Danish: Hertil hører P. aeruginosa, da disse bakteriers cellevæg har et højt indhold af fosfolipider.
English: What is Colobreathe used for?
Danish: Hvad anvendes Colobreathe til?
English: What benefit has Colobreathe shown during the studies?
Danish: Hvilken fordel viser undersøgelserne, at der er ved Colobreathe?
English: Colistimethate sodium is a well-known antibiotic that has been used for several years to treat lung infection in cystic fibrosis patients and is available in the form of a solution used with a nebuliser (a machine that changes a solution into an aerosol that the patient can breathe in).
Danish: Colistimethatnatrium er et velkendt antibiotikum, der har været anvendt i flere år til behandling af lungebetændelse ved cystisk fibrose.
English: How is Colobreathe used?
Danish: Hvordan anvendes Colobreathe?
English: How does Colobreathe work?
Danish: Hvordan virker Colobreathe?
English: Some Members States have both indications.
Danish: I nogle medlemsstater anvendes begge indikationer.
English: Overall, an estimated 70%-80% of the allergy tests performed were positive.
Danish: Totalt skønnes 70 % -80 % af de udførte allergitest at have været positive.